EQUILLIUM, INC. EQ Balance Sheet

Equillium, inc. (EQ)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Dec'17
Assets
Current assets:
Cash and cash equivalents
20,614	13,219	27,657	22,661	21,394	28,508	4,982	7,103
Short-term investments
27,061	39,924	34,581	34,283	40,213	37,405	-	0
Prepaid expenses and other current assets
2,147	2,288	671	852	1,022	1,186	77	45
Total current assets
49,822	55,431	62,909	57,796	62,629	67,099	5,060	7,149
Property and equipment, net
89	93	71	77	83	64	31	2
Other assets
-	15	15	15	15	-	-	-
Deferred offering costs
-	-	-	-	-	-	1,329	-
Total assets
49,911	55,539	62,995	57,888	62,727	67,163	6,421	7,151
Liabilities and stockholders' equity
Current liabilities:
Accounts payable
1,801	1,873	2,675	1,974	1,588	1,119	1,230	243
Accrued expenses
1,910	2,010	1,599	1,688	1,464	909	1,449	325
Total current liabilities
3,711	3,883	4,274	3,662	3,052	2,028	2,679	568
Long-term notes payable
9,746	9,681	9,616	-	-	-	-	-
Non-current liabilities
-	-	-	163	181	-	-	-
Long-term convertible promissory notes
-	-	-	-	-	-	10,321	6,994
Long-term convertible promissory notes, related party
-	-	-	-	-	-	1,274	1,064
Biocon anti-dilution right
-	-	-	-	-	-	2,375	775
Other non-current liabilities
108	127	146	-	-	200	148	-
Total liabilities
13,565	13,691	14,036	3,825	3,233	2,228	16,800	9,403
Commitments and contingencies
-	-	-	-	-	-	0	-
Stockholders' equity:
Common stock, $0.0001 par value; 200,000,000 shares authorized; 17,683,965 and 17,425,654 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively
1	1	1	1	1	1	0	0
Additional paid-in capital
84,820	82,938	82,423	81,506	80,906	80,441	141	9
Accumulated other comprehensive income
474	21	80	87	49	5	-	-
Accumulated deficit
-48,949	-41,112	-33,545	-27,531	-21,462	-15,512	-10,520	-2,261
Total stockholders' equity
36,346	41,848	48,959	54,063	59,494	64,935	-10,378	-2,252
Total liabilities and stockholders' equity
49,911	55,539	62,995	57,888	62,727	67,163	6,421	7,151